Murineddu M - Search Results

1

[Current views of thalassemia intermedia].

Longinotti M, Dore F, Oggiano L, Pardini S, Pistidda P, Guiso L, Frogheri L, Bonfigli S, Murineddu M, Rimini E. Longinotti M, et al. Among authors: murineddu m. Recenti Prog Med. 1992 Apr;83(4):233-40. Recenti Prog Med. 1992. PMID: 1626119 Review. Italian.

2

[Differential diagnosis of thalassemia syndromes].

Dore F, Pardini S, Bonfigli S, Oggiano L, Murineddu M, Pistidda P, Guiso L, Frogheri L, Gaviano E, Longinotti M. Dore F, et al. Among authors: murineddu m. Ann Ital Med Int. 1992 Jan-Mar;7(1):34-41. Ann Ital Med Int. 1992. PMID: 1381931 Review. Italian.

3

Incidence and clinical study of ectopic erythropoiesis in adult patients with thalassemia intermedia.

Dore F, Cianciulli P, Rovasio S, Oggiano L, Bonfigli S, Murineddu M, Pardini S, Simonetti G, Gualdi G, Papa G, et al. Dore F, et al. Among authors: murineddu m. Ann Ital Med Int. 1992 Jul-Sep;7(3):137-40. Ann Ital Med Int. 1992. PMID: 1457252

4

Alpha 2b-interferon therapy and pregnancy--report of a case of essential thrombocythemia.

Pardini S, Dore F, Murineddu M, Bontigli S, Longinotti M, Grigliotti B, Spano B. Pardini S, et al. Among authors: murineddu m. Am J Hematol. 1993 May;43(1):78-9. doi: 10.1002/ajh.2830430125. Am J Hematol. 1993. PMID: 8317474 No abstract available.

5

Patients with early-stage myelodysplastic syndromes show increased frequency of CD4+CD25+CD127(low) regulatory T cells.

Fozza C, Longu F, Contini S, Galleu A, Virdis P, Bonfigli S, Murineddu M, Gabbas A, Longinotti M. Fozza C, et al. Among authors: murineddu m. Acta Haematol. 2012;128(3):178-82. doi: 10.1159/000339498. Epub 2012 Aug 10. Acta Haematol. 2012. PMID: 22890368

6

Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.

Monne M, Piras G, Palmas A, Arru L, Murineddu M, Latte G, Noli A, Gabbas A. Monne M, et al. Among authors: murineddu m. Am J Hematol. 2004 May;76(1):14-8. doi: 10.1002/ajh.20045. Am J Hematol. 2004. PMID: 15114591 Free article.

7

Risk of malignant lymphoma following viral hepatitis infection.

Cocco P, Piras G, Monne M, Uras A, Gabbas A, Ennas MG, Palmas A, Murineddu M, Collu S, Melis M, Rais M, Todde P, Cabras MG, Angelucci E, Massarelli G, Nieters A. Cocco P, et al. Among authors: murineddu m. Int J Hematol. 2008 Jun;87(5):474-483. doi: 10.1007/s12185-008-0086-3. Epub 2008 May 1. Int J Hematol. 2008. PMID: 18446278

8

Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.

Della Peruta M, Martinelli G, Moratti E, Pintani D, Vezzalini M, Mafficini A, Grafone T, Iacobucci I, Soverini S, Murineddu M, Vinante F, Tecchio C, Piras G, Gabbas A, Monne M, Sorio C. Della Peruta M, et al. Among authors: murineddu m. Cancer Res. 2010 Nov 1;70(21):8896-906. doi: 10.1158/0008-5472.CAN-10-0258. Epub 2010 Oct 19. Cancer Res. 2010. PMID: 20959494

9

Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma.

Piras G, Monne M, Uras A, Palmas A, Murineddu M, Arru L, Bianchi A, Calvisi A, Curreli L, Gaviano E, Lai P, Murgia A, Latte GC, Noli A, Gabbas A. Piras G, et al. Among authors: murineddu m. Br J Haematol. 2005 Jun;129(6):784-90. doi: 10.1111/j.1365-2141.2005.05525.x. Br J Haematol. 2005. PMID: 15953005 Free article.

10

Pomalidomide in heavily pretreated refractory multiple myeloma: a case report.

Palmas A, Piras G, Uras A, Asproni R, Murineddu M, Monne M, Stradoni R, Latte G. Palmas A, et al. Among authors: murineddu m. Future Oncol. 2017 Feb;13(5s):7-9. doi: 10.2217/fon-2016-0460. Future Oncol. 2017. PMID: 28116939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters